Effects of L-DOPA on spatiotemporal contrast sensitivity in Parkinson's disease.
Mestre
D R
DR
URA CNRS 1166, Marseille, France.
Blin
O
O
van den Brand
C L
CL
Azulay
J P
JP
Serratrice
G
G
D000368:Aged; D000369:Aged, 80 and over; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D015350:Contrast Sensitivity / Q000187:drug effects*; D018450:Disease Progression; D005260:Female; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009068:Movement / Q000502:physiology; D010300:Parkinson Disease / Q000188:drug therapy* / Q000523:psychology*; D013028:Space Perception / Q000187:drug effects; D013998:Time Perception / Q000187:drug effects
D000978:Antiparkinson Agents; D007980:Levodopa